Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-056561)

Filing Details

Accession Number:: 0001209191-13-056561
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-12-12 16:05:28
Reporting Period:: 2013-12-11

Filing Date:: 2013-12-12
Accepted Time:: 2013-12-12 16:05:28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1182129	Auxilium Pharmaceuticals Inc	AUXL	Pharmaceutical Preparations (2834)	233016883

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1327442	E James Fickenscher	C/O Auxilium Pharmaceuticals, Inc 640 Lee Road Chesterbrook PA 19087	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-12-11	71,067	$4.78	116,199	No	4	M	Direct
Common Stock	Disposition	2013-12-11	71,067	$20.37	45,132	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Employee Stock Option (right to buy)	Disposition	2013-12-11	71,067	$0.00	71,067	$4.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-05-18	2015-05-18	No	4	M	Direct

Footnotes

The options have been exercised and the underlying shares sold pursuant to a Rule 10b5-1 Plan dated November 11, 2013.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.09 to $20.79, inclusive.